Nitromint (Glyceryl Trinitrate)

Nitromint (glyceryl trinitrate) is employed in the management of coronary artery disease and related conditions.

• Angina pectoris: provides rapid relief of chest pain by dilating coronary vessels.
• Prevention of angina attacks: reduces the frequency of episodes through sustained vasodilation.
• Heart failure: improves cardiac output by decreasing preload and afterload.

• Glyceryl trinitrate releases nitric oxide within vascular smooth muscle, activating guanylate cyclase and raising cyclic GMP levels. Elevated cGMP induces relaxation of venous and arterial smooth muscle, producing venodilation and arterial dilation that lower cardiac preload and afterload, thereby reducing myocardial oxygen demand.

Nitromint may cause several adverse reactions, ranging from common, mild events to rare, serious conditions.

Common Side Effects

• Headache: throbbing pain often occurring shortly after application.
• Dizziness or light‑headedness: due to reduced blood pressure.
• Flushing: warmth and redness of the skin, especially on the face.
• Skin irritation at the patch site: redness, itching or rash.
• Tachycardia: compensatory increase in heart rate.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure that may cause fainting.
• Syncope: sudden loss of consciousness.
• Myocardial infarction: rare occurrence of heart attack.
• Allergic reaction: rash, swelling, or difficulty breathing.
• Methemoglobinemia: abnormal hemoglobin leading to cyanosis.

Before using Nitromint, consider the following precautions and warnings.

• Severe hypotension: avoid use in patients with low blood pressure.
• Concomitant use of phosphodiesterase‑5 inhibitors: risk of profound hypotension.
• Recent myocardial infarction: use only under close medical supervision.
• Surgery or anesthesia: discontinue patch prior to procedures as advised.
• Development of tolerance: rotate patch application sites to minimize tolerance.
• Store at room temperature: keep in the original pack, protect from moisture and light.

Nitromint can interact with several medicines; awareness of these interactions helps prevent adverse events.

Major Interactions (Avoid)

• Other nitrates (e.g., isosorbide dinitrate): additive vasodilatory effect causing severe hypotension.
• Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may lead to dangerous blood pressure drops.
• Hypotensive agents (e.g., hydralazine): increase risk of excessive blood pressure reduction.
• Alcohol: can potentiate hypotensive effects.
• Severe anemia: may exacerbate low oxygen delivery.

Moderate Interactions (Monitor Closely)

• Antihypertensives (beta‑blockers, ACE inhibitors): monitor blood pressure.
• Diuretics: watch for volume depletion and hypotension.
• Antiplatelet agents (aspirin, clopidogrel): increased bleeding risk.
• Certain antibiotics (macrolides, azoles): may affect metabolism of nitrates.
• Smoking: induces tolerance, may reduce efficacy.